Avian Coryza (Infectious Coryza) in Chickens: Etiology, Diagnosis, and Management
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Avian coryza is an acute upper respiratory bacterial disease in chickens caused by Avibacterium paragallinarum, characterized by serous to mucopurulent nasal discharge, facial edema, and a significant drop in egg production.
- Transmission is horizontal via aerosolized droplets, direct contact, and contaminated fomites, with carrier birds perpetuating endemicity, particularly in multi-age layer and breeder operations.
- Diagnosis relies on isolation and identification of A. paragallinarum via selective culture media and NAD supplementation, with PCR targeting the HMTp210 gene for species confirmation and differentiation of pathogenic from nonpathogenic strains.
- Antimicrobial therapy with tetracyclines, sulfonamide-trimethoprim, tylosin, erythromycin, or fluoroquinolones is indicated, though antimicrobial resistance is an emerging concern requiring susceptibility testing.
- Control strategies emphasize strict biosecurity measures, including all-in/all-out management and quarantine, alongside vaccination with inactivated bacterins covering serovars A, B, and C for serovar-specific protection.
- Eradication efforts in low-prevalence regions can be successful through test-and-slaughter programs, but the presence of nonpathogenic carrier strains complicates diagnosis and culling decisions.
Introduction
Avian coryza, termed infectious coryza (IC) in the clinical literature, is an acute upper respiratory bacterial disease of chickens caused by Avibacterium paragallinarum [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease is characterized by serous to mucopurulent nasal discharge, facial edema, lacrimation, and a marked drop in egg production in laying flocks [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. Although morbidity can approach 100%, mortality is typically low unless complicated by secondary pathogens or poor environmental conditions [<a href="#ref-1">1</a>]. Infectious coryza remains a significant economic burden to the poultry industry worldwide, particularly in multi-age layer and breeder operations where the pathogen becomes endemic [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>].
Recent advances in genomics, molecular serotyping, and vaccine development have deepened the understanding of A. paragallinarum heterogeneity and host-pathogen interactions [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. This article provides a thorough, publication-grade review of the etiology, diagnosis, treatment, and management of avian coryza, drawing exclusively on the most recent peer-reviewed literature.
Etiology
Causative Agent
The disease is caused by Avibacterium paragallinarum, a Gram-negative, non-motile, pleomorphic, facultative anaerobic coccobacillus belonging to the family Pasteurellaceae [<a href="#ref-1">1</a>]. The organism was originally classified as Haemophilus paragallinarum before reclassification to the genus Avibacterium. It requires nicotinamide adenine dinucleotide (NAD, factor V) for in vitro growth and can be cultivated on chocolate agar or specific selective media [<a href="#ref-10">10</a>]. Satellite growth near Staphylococcus nurse colonies is a typical diagnostic feature.
Serotyping and Genotyping
Classical serotyping of A. paragallinarum is based on the Page scheme, which identifies three serovars (A, B, C) using agglutination or hemagglutination-inhibition (HI) tests. The hemagglutinin antigen HMTp210 is the primary serovar-defining immunogen [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. Recent studies have proposed a genotyping method based on the HMTp210 gene as an alternative to classical serotyping, revealing additional diversity [<a href="#ref-12">12</a>]. Molecular serotyping approaches have identified emerging genotypes, including serovar B variants in Argentina [<a href="#ref-13">13</a>] and novel genotypes in Iran [<a href="#ref-8">8</a>] and China [<a href="#ref-9">9</a>, <a href="#ref-14">14</a>]. Nonpathogenic genotypes have also been isolated from healthy layer flocks in the United States, indicating a carrier state that complicates diagnosis [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>].
Virulence Factors
Key virulence determinants include the capsular polysaccharide (CPS) and lipooligosaccharide (LOS), whose biosynthetic loci have been recently characterized [<a href="#ref-18">18</a>]. Biofilm formation, mediated by genes identified through random transposon mutagenesis, contributes to persistence on fomites and within the host [<a href="#ref-19">19</a>]. Natural transformation competence allows horizontal acquisition of antibiotic resistance genes, including those transferred via outer membrane vesicles [<a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. Highly virulent strains produce pronounced inflammation and rapid onset of clinical signs, while nonpathogenic isolates lack key virulence-associated genes [<a href="#ref-15">15</a>, <a href="#ref-22">22</a>].
Epidemiology
Host Range and Transmission
Avibacterium paragallinarum primarily infects chickens and, to a lesser extent, quail and pheasants [<a href="#ref-1">1</a>]. The infection is host-specific and does not affect mammals. Transmission occurs horizontally via aerosolized respiratory droplets, direct contact, and contaminated fomites such as feed, water, and equipment [<a href="#ref-5">5</a>]. The incubation period ranges from 24 to 48 hours after experimental challenge [<a href="#ref-13">13</a>]. Carrier birds, including those infected with nonpathogenic strains, can shed the bacterium intermittently, perpetuating flock endemicity [<a href="#ref-15">15</a>, <a href="#ref-17">17</a>].
Prevalence and Risk Factors
A meta-analysis of poultry populations in China spanning 1993-2024 reported an overall prevalence of 18.7%, with higher rates in layers than in broilers [<a href="#ref-23">23</a>]. Risk factors identified in case-control studies include large flock size, poor biosecurity, introduction of replacement birds without quarantine, and proximity to other poultry operations [<a href="#ref-5">5</a>]. In California, a retrospective analysis of outbreaks from 2016-2022 showed spatiotemporal clustering and association with multi-age layer complexes [<a href="#ref-6">6</a>]. In Alberta, a table-egg layer flock outbreak was linked to purchase of pullets from an infected source [<a href="#ref-3">3</a>]. Co-infections with Ornithobacterium rhinotracheale or Mycoplasma gallisepticum exacerbate clinical severity [<a href="#ref-24">24</a>].
Clinical Signs and Pathology
Clinical Presentation
The classic signs of avian coryza include serous nasal discharge that progresses to mucopurulent or purulent exudate, conjunctivitis, facial edema (particularly of the infraorbital sinuses and wattles), and sneezing [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>]. In laying hens, egg production can drop by 10-40% within days [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>]. Feed and water consumption decrease, and stunting may be observed in growing birds. Mortality is low (<5%) unless respiratory complications or secondary infections occur [<a href="#ref-1">1</a>]. Subclinical infections are common and may be detected only by serology or molecular screening of apparently healthy flocks [<a href="#ref-17">17</a>].
Pathology
Gross lesions are confined to the upper respiratory tract: hemorrhagic or catarrhal rhinitis, sinusitis, and laryngotracheitis. Fibrino-purulent exudate may fill the infraorbital sinuses [<a href="#ref-1">1</a>]. In chronic cases, airsacculitis and pneumonia can occur, especially when co-infections are present [<a href="#ref-24">24</a>]. Histopathology reveals hyperemia, edema, and infiltration of heterophils and macrophages in the nasal mucosa and sinuses.
Diagnosis
A diagnostic algorithm is presented in Figure 1.
flowchart TD
A["Chicken with nasal discharge, facial edema"] --> B{"Clinical suspicion?"}
B -->|"Yes"| C["Collect nasal swab / sinus exudate"]
C --> D["Gram stain: Gram-negative pleomorphic rods"]
D --> E["Isolation on selective media with NAD"]
E --> F["Satellite test / biochemical identification"]
F --> G["Species confirmation: PCR targeting HMTp210"]
G --> H{"Pathogenic vs. nonpathogenic?"}
H -->|"Pathogenic"| I["Quantify pathogen load"]
H -->|"Nonpathogenic"| J["Consider carrier state"]
I --> K["Antimicrobial susceptibility testing (broth microdilution)"]
K --> L["Select targeted therapy"]
G --> M["Genotyping / MLST for epidemiology"]Figure 1. Diagnostic workflow for avian coryza. Adapted from references [<a href="#ref-10">10</a>, <a href="#ref-25">25</a>, <a href="#ref-26">26</a>, <a href="#ref-27">27</a>].
Sample Collection and Culture
Nasal swabs, sinus exudate, or tracheal samples should be collected from acutely affected birds and placed in transport medium [<a href="#ref-10">10</a>]. Selective culture media, such as modified blood agar supplemented with NAD, trimethoprim, and other inhibitors, have been developed to improve isolation rates from contaminated samples [<a href="#ref-10">10</a>]. Colonies appear as dewdrop-like after 24-48 hours microaerophilic incubation at 37°C. Biochemical characterization includes catalase and oxidase activity, nitrate reduction, and lack of urease production [<a href="#ref-1">1</a>].
Molecular Diagnostics
PCR assays targeting the HMTp210 gene are the standard for species confirmation [<a href="#ref-12">12</a>, <a href="#ref-26">26</a>]. Discriminatory PCRs have been developed to differentiate pathogenic from nonpathogenic A. paragallinarum by targeting specific virulence-associated sequences [<a href="#ref-25">25</a>]. Real-time quantitative PCR provides rapid detection and load estimation. For epidemiological typing, a genome-guided multilocus sequence typing (MLST) scheme has been validated against traditional serotyping [<a href="#ref-7">7</a>]. Whole-genome sequencing is increasingly used for outbreak investigations and resistance gene profiling [<a href="#ref-21">21</a>, <a href="#ref-28">28</a>].
Serology
Serological testing using hemagglutination-inhibition (HI) or commercial ELISA kits can detect antibodies at the flock level, but cross-reactions with other Pasteurellaceae may occur. HI titers correlate with protection following vaccination [<a href="#ref-13">13</a>, <a href="#ref-29">29</a>]. Serology is less useful for acute diagnosis due to the delay in seroconversion (7-10 days).
Differential Diagnosis
Several respiratory diseases present similarly and must be distinguished (Table 1).
Table 1. Differential diagnoses for avian coryza in chickens.
| Condition | Key distinguishing features | Reference |
|---|---|---|
| Avian influenza (HPAI/LPAI) | Systemic signs, high mortality in HPAI; PCR or virus isolation | , |
| Infectious laryngotracheitis (ILT) | Gasping, bloody tracheal exudate; intranuclear inclusion bodies | [<a href="#ref-2">2</a>] |
| Mycoplasmosis (M. gallisepticum)* | Chronic respiratory disease; airsacculitis; serology | , |
| Fowl cholera (Pasteurella multocida)* | Septicemia, swollen wattles (chronic); Gram-negative bipolar rods | , |
| Avian colibacillosis (E. coli)* | Secondary infection; pericarditis, airsacculitis | , |
| Ornithobacterium rhinotracheale | Co-infection common; severe airsacculitis | [<a href="#ref-24">24</a>] |
*Links to relevant articles: Infectious Coryza in Poultry and Ducks, Avian Coryza in Poultry.
Treatment
Antimicrobial Therapy
Therapeutic intervention aims to reduce clinical signs, limit transmission, and restore production. Antibiotics effective against A. paragallinarum include tetracyclines, sulfonamide-trimethoprim combinations, tylosin, erythromycin, and fluoroquinolones [<a href="#ref-1">1</a>]. However, antimicrobial resistance is an emerging concern. A standardized broth microdilution method for susceptibility testing has been recommended to harmonize monitoring [<a href="#ref-27">27</a>]. Resistance genes, including those encoding β-lactamases and tetracycline efflux pumps, have been identified in Chinese isolates [<a href="#ref-28">28</a>]. Genomic analysis reveals that antibiotic resistance can be transferred horizontally via outer membrane vesicles [<a href="#ref-21">21</a>].
Alternative Therapeutics
Chinese herbal medicine extracts have demonstrated bacteriostatic activity in vitro [<a href="#ref-30">30</a>]. Probiotics combined with berry phenolic extracts reduced A. paragallinarum viability in experimental models [<a href="#ref-31">31</a>]. Polymeric nanocarrier-based adjuvants have been developed to enhance mucosal vaccine efficacy [<a href="#ref-29">29</a>]. These non-antibiotic strategies are currently adjunctive and require further field validation.
Management and Control
Biosecurity
Prevention relies on strict biosecurity: all-in/all-out management, quarantine of incoming birds, cleaning and disinfection of facilities, control of personnel and equipment movement, and vermin control [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Flocks with a known history of IC should be depopulated and facilities thoroughly cleaned before restocking. The bacterium can survive in organic material for several days, necessitating use of effective disinfectants.
Vaccination
Both inactivated (bacterin) and live attenuated vaccines are available. Killed vaccines containing serovars A, B, and C are commonly used in layers and breeders, providing serovar-specific protection [<a href="#ref-13">13</a>]. A live attenuated vaccine candidate developed through counterselection genetic manipulation has shown promise in experimental trials [<a href="#ref-32">32</a>, <a href="#ref-33">33</a>]. Efficacy of different vaccination plans against a serovar B variant in Argentina demonstrated that two doses with an oil-adjuvanted vaccine reduced clinical signs and egg drop [<a href="#ref-13">13</a>]. Probiotics such as Enterococcus faecium can improve vaccine immune responses [<a href="#ref-34">34</a>]. Mucosal vaccines with polymeric nanocarrier adjuvants enhance local IgA and HI titers [<a href="#ref-29">29</a>].
Eradication
In regions with low prevalence (e.g., many European countries), test-and-slaughter programs combined with strict biosecurity have successfully eliminated IC from commercial flocks [<a href="#ref-1">1</a>]. However, the recent identification of nonpathogenic carrier strains complicates eradication efforts, as these birds shed bacteria without showing signs [<a href="#ref-17">17</a>]. Differentiating pathogenic from nonpathogenic strains using the PCR method of Shelkamy et al. is critical for making culling decisions [<a href="#ref-25">25</a>].
Avian Coryn Search Term Integration
The term avian coryn is an abbreviated variant sometimes used in literature indexing. Under this heading, the disease must be categorized as a bacterial respiratory condition of poultry distinct from viral causes. The avian coryn pathogen A. paragallinarum shares ecological niches with other avian coryza agents but is uniquely characterized by NAD dependence and HMTp210-mediated serovar specificity.
Future Directions
Research priorities include understanding the role of nonpathogenic A. paragallinarum in flock dynamics [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>], development of cross-protective vaccines against emerging serovars [<a href="#ref-13">13</a>], and refinement of point-of-care molecular diagnostics that can distinguish pathogenic from nonpathogenic isolates [<a href="#ref-25">25</a>]. Genomic surveillance using standardized MLST [<a href="#ref-7">7</a>] and whole-genome sequencing [<a href="#ref-35">35</a>] will enhance outbreak tracking. Additionally, integrated control strategies combining probiotics, herbal bacteriostats, and targeted antimicrobial use are needed to reduce reliance on antibiotics [<a href="#ref-30">30</a>, <a href="#ref-31">31</a>].